BIRC5 and cancer: A total of 207 chemical structure analogs relevant to the 20 hit compounds were then analyzed for their inhibition of survivin promoter activity in the generated model cells in parallel with determination of cancer cell growth inhibition by each compound in vitro via MTT assay.